Full bill text rendering is coming soon.
In the meantime, read the full text on Congress.gov ↗.
Core Policy Mechanism Top 4
Computable Cancer Screening Guideline Framework
Requires federal health IT officials to build and annually update a public, machine-readable cancer screening framework based on USPSTF and NCI guidelines, making screening recommendations accessible through interoperable health technology.
- Population Scope High The publicly available machine-readable framework shapes cancer screening guidance for virtually every patient and clinician using certified health IT systems, reaching well over 25% of the U.S. population.
- Budgetary Magnitude Low No appropriation, dollar amount, or funding stream is authorized or allocated for establishing or maintaining this framework.
- Legal / Regulatory Depth High New section 3009B of the Public Health Service Act creates a binding statutory mandate on the National Coordinator for Health Information Technology (ONC) to establish and annually update a federal cancer screening standard — a new affirmative duty that did not previously exist in law.
- Degree of Discretion Granted Medium The 'shall establish' mandate is binding, but the National Coordinator retains meaningful discretion in how the framework is structured, which data elements are included, and how consultations with AHRQ, United States Preventive Services Task Force (USPSTF), National Cancer Institute (NCI), and Centers for Disease Control and Prevention (CDC) are conducted.
- Implementation & Enforcement Burden Low The provision imposes an administrative production duty on ONC with no enforcement mechanism, penalty, or compliance obligation on any external party.
- Temporal Commitment High The annual update cycle continues indefinitely with no sunset or reauthorization trigger, persisting until Congress affirmatively acts to repeal it.
No signal yet
Regulatory or Legal Changes Top 4
EHR Certification Condition for Cancer Screening
Requires certified electronic health record (EHR) systems to include functionality that tracks individual patients' cancer screening status against federal guidelines within five years, with privacy protections limiting data use to the minimum necessary.
- Population Scope High The condition applies to all certified EHR systems used across U.S. healthcare, directly affecting EHR vendors and the hundreds of millions of patients whose records are maintained in those systems.
- Budgetary Magnitude Low No appropriation, dollar amount, or funding stream is authorized or allocated for this certification condition.
- Legal / Regulatory Depth High New subparagraph (E) adds a binding condition of certification to Section 3001(c)(5) of the Public Health Service Act, creating an enforceable statutory obligation that EHR vendors must satisfy to maintain federal market access — a substantive new legal constraint on an entire industry.
- Degree of Discretion Granted Medium Notice-and-comment rulemaking is mandatory within five years, but the Secretary of Health and Human Services (HHS) retains significant discretion in defining the specific technical and operational requirements EHR systems must meet.
- Implementation & Enforcement Burden Medium Conditioning federal EHR certification on compliance creates an affirmative recurring compliance obligation for all vendors, enforced through the existing certification program — a substantial industry-wide burden without requiring new enforcement infrastructure.
- Temporal Commitment High As a permanent amendment to the Public Health Service Act with no sunset or reauthorization requirement, the certification condition persists indefinitely until Congress acts to remove it.
No signal yet
Core Policy Mechanism Top 4
HHS Guidance for Health Plans on Cancer Screening Tools
Directs HHS to issue guidance within two years encouraging Medicaid managed care, Medicare Advantage, and marketplace health plans to integrate cancer screening recommendation technology and let patients opt into tools that track their screening status.
- Population Scope High The guidance targets Medicaid managed care, Medicare Advantage, and ACA marketplace plans collectively covering well over 100 million enrollees, reaching a very large share of the U.S. population.
- Budgetary Magnitude Low No appropriation, dollar amount, or funding stream is authorized or allocated; guidance issuance does not itself direct funds to any recipient.
- Legal / Regulatory Depth Medium Section 3 creates a new statutory duty for the Secretary of Health and Human Services (HHS) to issue guidance, but the guidance itself is non-binding encouragement — a procedural mandate on the agency without substantive legal effect on health plans.
- Degree of Discretion Granted High The Secretary of Health and Human Services must issue guidance but retains near-total discretion over its content, scope, and prescriptiveness, and health plans face no binding obligation to comply with any resulting guidance.
- Implementation & Enforcement Burden Low Because guidance is non-binding and no enforcement mechanism or compliance obligation attaches to health plans, the only burden is the agency's internal task of producing the guidance document.
- Temporal Commitment High As a permanent statutory amendment with no sunset or reauthorization requirement, the guidance duty persists indefinitely until Congress acts to repeal it.
No signal yet
Core Policy Mechanism Top 4
PCORI Authority for Cancer Screening Research
Expands the Patient-Centered Outcomes Research Institute (PCORI) mission to allow it to fund research, pilot projects, and clinical decision support tools that translate evidence-based cancer screening recommendations into interoperable health technology.
- Population Scope Medium The expansion directly affects the Patient-Centered Outcomes Research Institute (PCORI), grant applicants, and research institutions, with indirect downstream benefits to patients — a moderately broad but primarily institutional population.
- Budgetary Magnitude Low No new appropriation is created; the provision expands permissible uses of existing PCORI funds without directing any specific dollar amount.
- Legal / Regulatory Depth Medium New subparagraph (C) expands PCORI's statutory authority to cover a new category of permissive research activities — a meaningful enlargement of the Institute's mandate, though the permissive 'may support' language limits its substantive legal force.
- Degree of Discretion Granted High PCORI 'may support' the listed activities with no binding obligation, leaving the Institute complete discretion over whether, how much, and in what form to fund cancer screening research and pilots.
- Implementation & Enforcement Burden Low No enforcement mechanism, penalty, or external compliance obligation is created; PCORI's grant processes operate entirely within its existing governance structure.
- Temporal Commitment High As a permanent amendment to the Social Security Act with no sunset or reauthorization requirement, the expanded authority persists indefinitely until Congress acts to remove it.
No signal yet
No possible riders have been surfaced for this bill.
Summary
The SCREENS Act directs the National Coordinator for Health Information Technology to build a public, machine-readable framework of cancer screening recommendations — based on United States Preventive Services Task Force (USPSTF) and National Cancer Institute (NCI) guidelines — that electronic health record systems must incorporate within five years as a condition of federal certification. It also directs the Secretary of Health and Human Services (HHS) to issue guidance encouraging health plans to integrate those recommendations and let patients opt into tools that track their screening status. Finally, it expands the Patient-Centered Outcomes Research Institute (PCORI) mission to support research and pilot projects advancing interoperable cancer screening technology.
AI-generated summary, pending human review.
| Version | Event | Date | User support | Your vote | Roll calls |
|---|---|---|---|---|---|
| Original |
Initial publication
Sep 24, 2026
|
Sep 24, 2026 | No votes yet | — | — |
Log in or create an account to record your vote on this legislation. Results are visible to all visitors.
Core Policy Mechanism Top 4
Computable Cancer Screening Guideline Framework
Requires federal health IT officials to build and annually update a public, machine-readable cancer screening framework based on USPSTF and NCI guidelines, making screening recommendations accessible through interoperable health technology.
- Population Scope High The publicly available machine-readable framework shapes cancer screening guidance for virtually every patient and clinician using certified health IT systems, reaching well over 25% of the U.S. population.
- Budgetary Magnitude Low No appropriation, dollar amount, or funding stream is authorized or allocated for establishing or maintaining this framework.
- Legal / Regulatory Depth High New section 3009B of the Public Health Service Act creates a binding statutory mandate on the National Coordinator for Health Information Technology (ONC) to establish and annually update a federal cancer screening standard — a new affirmative duty that did not previously exist in law.
- Degree of Discretion Granted Medium The 'shall establish' mandate is binding, but the National Coordinator retains meaningful discretion in how the framework is structured, which data elements are included, and how consultations with AHRQ, United States Preventive Services Task Force (USPSTF), National Cancer Institute (NCI), and Centers for Disease Control and Prevention (CDC) are conducted.
- Implementation & Enforcement Burden Low The provision imposes an administrative production duty on ONC with no enforcement mechanism, penalty, or compliance obligation on any external party.
- Temporal Commitment High The annual update cycle continues indefinitely with no sunset or reauthorization trigger, persisting until Congress affirmatively acts to repeal it.
No signal yet
Core Policy Mechanism
Computable Cancer Screening Guideline Framework
Regulatory or Legal Changes Top 4
EHR Certification Condition for Cancer Screening
Requires certified electronic health record (EHR) systems to include functionality that tracks individual patients' cancer screening status against federal guidelines within five years, with privacy protections limiting data use to the minimum necessary.
- Population Scope High The condition applies to all certified EHR systems used across U.S. healthcare, directly affecting EHR vendors and the hundreds of millions of patients whose records are maintained in those systems.
- Budgetary Magnitude Low No appropriation, dollar amount, or funding stream is authorized or allocated for this certification condition.
- Legal / Regulatory Depth High New subparagraph (E) adds a binding condition of certification to Section 3001(c)(5) of the Public Health Service Act, creating an enforceable statutory obligation that EHR vendors must satisfy to maintain federal market access — a substantive new legal constraint on an entire industry.
- Degree of Discretion Granted Medium Notice-and-comment rulemaking is mandatory within five years, but the Secretary of Health and Human Services (HHS) retains significant discretion in defining the specific technical and operational requirements EHR systems must meet.
- Implementation & Enforcement Burden Medium Conditioning federal EHR certification on compliance creates an affirmative recurring compliance obligation for all vendors, enforced through the existing certification program — a substantial industry-wide burden without requiring new enforcement infrastructure.
- Temporal Commitment High As a permanent amendment to the Public Health Service Act with no sunset or reauthorization requirement, the certification condition persists indefinitely until Congress acts to remove it.
No signal yet
Regulatory or Legal Changes
EHR Certification Condition for Cancer Screening
Core Policy Mechanism Top 4
HHS Guidance for Health Plans on Cancer Screening Tools
Directs HHS to issue guidance within two years encouraging Medicaid managed care, Medicare Advantage, and marketplace health plans to integrate cancer screening recommendation technology and let patients opt into tools that track their screening status.
- Population Scope High The guidance targets Medicaid managed care, Medicare Advantage, and ACA marketplace plans collectively covering well over 100 million enrollees, reaching a very large share of the U.S. population.
- Budgetary Magnitude Low No appropriation, dollar amount, or funding stream is authorized or allocated; guidance issuance does not itself direct funds to any recipient.
- Legal / Regulatory Depth Medium Section 3 creates a new statutory duty for the Secretary of Health and Human Services (HHS) to issue guidance, but the guidance itself is non-binding encouragement — a procedural mandate on the agency without substantive legal effect on health plans.
- Degree of Discretion Granted High The Secretary of Health and Human Services must issue guidance but retains near-total discretion over its content, scope, and prescriptiveness, and health plans face no binding obligation to comply with any resulting guidance.
- Implementation & Enforcement Burden Low Because guidance is non-binding and no enforcement mechanism or compliance obligation attaches to health plans, the only burden is the agency's internal task of producing the guidance document.
- Temporal Commitment High As a permanent statutory amendment with no sunset or reauthorization requirement, the guidance duty persists indefinitely until Congress acts to repeal it.
No signal yet
Core Policy Mechanism
HHS Guidance for Health Plans on Cancer Screening Tools
Core Policy Mechanism Top 4
PCORI Authority for Cancer Screening Research
Expands the Patient-Centered Outcomes Research Institute (PCORI) mission to allow it to fund research, pilot projects, and clinical decision support tools that translate evidence-based cancer screening recommendations into interoperable health technology.
- Population Scope Medium The expansion directly affects the Patient-Centered Outcomes Research Institute (PCORI), grant applicants, and research institutions, with indirect downstream benefits to patients — a moderately broad but primarily institutional population.
- Budgetary Magnitude Low No new appropriation is created; the provision expands permissible uses of existing PCORI funds without directing any specific dollar amount.
- Legal / Regulatory Depth Medium New subparagraph (C) expands PCORI's statutory authority to cover a new category of permissive research activities — a meaningful enlargement of the Institute's mandate, though the permissive 'may support' language limits its substantive legal force.
- Degree of Discretion Granted High PCORI 'may support' the listed activities with no binding obligation, leaving the Institute complete discretion over whether, how much, and in what form to fund cancer screening research and pilots.
- Implementation & Enforcement Burden Low No enforcement mechanism, penalty, or external compliance obligation is created; PCORI's grant processes operate entirely within its existing governance structure.
- Temporal Commitment High As a permanent amendment to the Social Security Act with no sunset or reauthorization requirement, the expanded authority persists indefinitely until Congress acts to remove it.
No signal yet
Core Policy Mechanism
PCORI Authority for Cancer Screening Research
Incomplete vote
You have not made a selection on all required items:
Choose Neutral if you prefer not to commit. Leaving without completing will remove all your votes for this bill from the totals.
Maximum recommendations reached
You have already recommended the maximum number of components allowed on this bill. To recommend [new component], choose one of your current recommendations to unselect: